Publications
52
Citations
1,243
Est. group size
~6
Recurring co-author estimate
Active years
18
Publishing since 2009
This research profile centers on lung cancer, combining clinical trials of radiotherapy and targeted drug combinations with laboratory studies of DNA damage repair, metabolism, and cancer biology. Work spans clinical oncology (e.g., trials combining osimertinib with radiotherapy) and more basic molecular research (e.g., DNA repair pathways, mitochondrial metabolism, protein structure modeling). The publication list suggests involvement in both patient-focused treatment optimization and mechanistic cancer research, sometimes in collaboration with computational and structural biology groups.
Publication output was low and irregular from 2017–2022 but increased sharply starting in 2023, with roughly 10-12 papers per year through 2025, indicating a recent period of growing research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- LIPT1 loss confers replication stress and PARP inhibitor sensitivity through PrimPol-mediated ssDNA gaps
Science Advances · 2026
- Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non–small cell lung cancer: a multicentre, single-arm, phase 2 trial
EClinicalMedicine · 2025
- NUDT5 regulates purine metabolism and thiopurine sensitivity by interacting with PPAT
Science · 2025
- Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair
Science Advances · 2025
- Characteristics and risk factors for outcomes in patients with Mycoplasma pneumoniae mono- and coinfections: A multicenter surveillance study in Wuhan, China, 2023
Infectious Disease Modelling · 2025
- DMcloud: Macromolecular Structure Modeling with Local Structure Fitting for Medium to Low Resolution Cryo-EM Maps
Microscopy and Microanalysis · 2025
- Improving efficiency in lung SAbR planning using integrated tools for X‐ray based adaptive radiotherapy
Journal of Applied Clinical Medical Physics · 2025
- Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
- Antibacterial Efficacy of Chlamydomonas reinhardtii–Expressed Enterocin RM6 Against Gram-Positive and Gram-Negative Bacteria
Probiotics and Antimicrobial Proteins · 2025
- BPS2025 - Global and local model-map fitting for large macromolecular structure in cryo-EM maps using diffusion model
Biophysical Journal · 2025
- Exploring Strategies for Personalized Radiation Therapy: Part III Identifying genetic determinants for Radiation Response with Meta Learning
arXiv (Cornell University) · 2025
- Mitochondrial complex I promotes kidney cancer metastasis
Nature · 2024
- Unveiling the stochastic nature of human heteropolymer ferritin self‐assembly mechanism
Protein Science · 2024
- Adapt-On-Demand: A Novel Strategy for Personalized Adaptive Radiation Therapy for Locally Advanced Lung Cancer
Practical Radiation Oncology · 2024
- An AI-based approach for modeling the synergy between radiotherapy and immunotherapy
Scientific Reports · 2024
- International Journal of Radiation Oncology*Biology*Physics×5
- Science Advances×3
- Journal of Clinical Oncology×3
- Proteins Structure Function and Bioinformatics×2
- Scientific Reports×2
- M.X. Welliver
Medicine · The Ohio State University
- A. Foster
Medicine · Indiana University
- Wei Tang
Medicine · Indiana University
- Daniel Jones
Medicine · The Ohio State University
- Manny Coker‐Schwimmer
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile